{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T08:32:26Z","timestamp":1761381146631,"version":"build-2065373602"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The First Affiliated Hospital of Anhui University of Science and Technology","award":["YZ2023H2C006"],"award-info":[{"award-number":["YZ2023H2C006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s00203-025-04481-2","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T12:49:28Z","timestamp":1759754968000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A BCG-boosting subunit vaccine RS2\/DMI induces Th1-polarized immunity by targeting RD6 and secretory antigens of Mycobacterium tuberculosis"],"prefix":"10.1007","volume":"207","author":[{"given":"Xiaochun","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiangsen","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinkuang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"issue":"10481","key":"4481_CR1","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/S0140-6736(24)02479-6","volume":"405","author":"A Trajman","year":"2025","unstructured":"Trajman A, Campbell JR, Kunor T et al (2025) Tuberculosis. Lancet 405(10481):850\u2013866. https:\/\/doi.org\/10.1016\/S0140-6736(24)02479-6","journal-title":"Lancet"},{"issue":"2","key":"4481_CR2","doi-asserted-by":"publisher","first-page":"e20210033","DOI":"10.36416\/1806-3756\/e20210033","volume":"47","author":"EL Maciel","year":"2021","unstructured":"Maciel EL, Silva PEAD (2021) Fighting tuberculosis: from 1993 to 2035 during the COVID-19 era. J Bras Pneumol 47(2):e20210033. https:\/\/doi.org\/10.36416\/1806-3756\/e20210033","journal-title":"J Bras Pneumol"},{"key":"4481_CR3","unstructured":"Global tuberculosis report 2024 (2024) Geneva: World Health Organization https:\/\/www.who.int\/publications\/i\/item\/9789240101531"},{"key":"4481_CR4","doi-asserted-by":"publisher","first-page":"943545","DOI":"10.3389\/fcimb.2022.943545","volume":"12","author":"D Liebenberg","year":"2022","unstructured":"Liebenberg D, Gordhan BG, Kana BD (2022) Drug resistant tuberculosis: implications for transmission, diagnosis, and disease management. Front Cell Infect Microbiol 12:943545. https:\/\/doi.org\/10.3389\/fcimb.2022.943545","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"4481_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12879-020-05749-2","volume":"21","author":"ZZ Sultana","year":"2021","unstructured":"Sultana ZZ, Hoque FU, Beyene J et al (2021) HIV infection and multidrug resistant tuberculosis: a systematic review and meta-analysis. BMC Infect Dis 21(1):51. https:\/\/doi.org\/10.1186\/s12879-020-05749-2","journal-title":"BMC Infect Dis"},{"issue":"9","key":"4481_CR6","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.cmi.2023.10.023","volume":"30","author":"A Vasiliu","year":"2024","unstructured":"Vasiliu A, Martinez L, Gupta RK et al (2024) Tuberculosis prevention: current strategies and future directions. Clin Microbiol Infect 30(9):1123\u20131130. https:\/\/doi.org\/10.1016\/j.cmi.2023.10.023","journal-title":"Clin Microbiol Infect"},{"key":"4481_CR7","doi-asserted-by":"publisher","unstructured":"Cranmer LM, Cotton MF, Day CL, Nemes E (2022) What\u2019s Old and New in Tuberculosis Vaccines for Children. J Pediatr Infect Dis Soc11(Supplement_3) S110\u2013S116. https:\/\/doi.org\/10.1093\/jpids\/piac078","DOI":"10.1093\/jpids\/piac078"},{"issue":"0","key":"4481_CR8","first-page":"1259","volume":"70","author":"K Krysztopa-Grzybowska","year":"2016","unstructured":"Krysztopa-Grzybowska K, Luty\u0144ska A (2016) Microevolution of BCG substrains. Postepy Hig Med Dosw (Online) 70(0):1259\u20131266","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"4481_CR9","doi-asserted-by":"publisher","first-page":"29076","DOI":"10.1038\/srep29076","volume":"6","author":"V Tran","year":"2016","unstructured":"Tran V, Ahn SK, Ng M, Li M, Liu J (2016) Loss of lipid virulence factors reduces the efficacy of the BCG vaccine. Sci Rep 6:29076. https:\/\/doi.org\/10.1038\/srep29076","journal-title":"Sci Rep"},{"issue":"8","key":"4481_CR10","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1007\/s10875-022-01302-9","volume":"42","author":"PT Lyra","year":"2022","unstructured":"Lyra PT, Souza E, Moura ACA et al (2022) Inborn errors of immunity in patients with adverse events following BCG vaccination in Brazil. J Clin Immunol 42(8):1708\u20131720. https:\/\/doi.org\/10.1007\/s10875-022-01302-9","journal-title":"J Clin Immunol"},{"issue":"7","key":"4481_CR11","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1016\/j.jaip.2022.03.032","volume":"10","author":"A Laberko","year":"2022","unstructured":"Laberko A, Yukhacheva D, Kan N et al (2022) BCG infection in patients with inborn errors of immunity receiving the Russian BCG strain. J Allergy Clin Immunol Pract 10(7):1797\u20131804e7. https:\/\/doi.org\/10.1016\/j.jaip.2022.03.032","journal-title":"J Allergy Clin Immunol Pract"},{"key":"4481_CR12","doi-asserted-by":"publisher","first-page":"117594","DOI":"10.1016\/j.lfs.2020.117594","volume":"252","author":"S Fatima","year":"2020","unstructured":"Fatima S, Kumari A, Das G, Dwivedi VP (2020) Tuberculosis vaccine: A journey from BCG to present. Life Sci 252:117594. https:\/\/doi.org\/10.1016\/j.lfs.2020.117594","journal-title":"Life Sci"},{"key":"4481_CR13","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.ijid.2021.06.045","volume":"109","author":"B Trollfors","year":"2021","unstructured":"Trollfors B, Sigurdsson V, Dahlgren-Aronsson A (2021) Prevalence of latent TB and effectiveness of BCG vaccination against latent tuberculosis: an observational study. Int J Infect Dis 109:279\u2013282. https:\/\/doi.org\/10.1016\/j.ijid.2021.06.045","journal-title":"Int J Infect Dis"},{"issue":"4","key":"4481_CR14","doi-asserted-by":"publisher","first-page":"e26193","DOI":"10.1016\/j.heliyon.2024.e26193","volume":"10","author":"R Hoseinpour","year":"2024","unstructured":"Hoseinpour R, Hasani A, Baradaran B et al (2024) Tuberculosis vaccine developments and efficient delivery systems: A comprehensive appraisal. Heliyon 10(4):e26193. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e26193","journal-title":"Heliyon"},{"key":"4481_CR15","doi-asserted-by":"publisher","first-page":"583077","DOI":"10.3389\/fimmu.2020.583077","volume":"11","author":"M Brisse","year":"2020","unstructured":"Brisse M, Vrba SM, Kirk N, Liang Y, Ly H (2020) Emerging concepts and technologies in vaccine development. Front Immunol 11:583077. https:\/\/doi.org\/10.3389\/fimmu.2020.583077","journal-title":"Front Immunol"},{"issue":"3","key":"4481_CR16","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1016\/S1473-3099(19)30625-5","volume":"20","author":"LK Schrager","year":"2020","unstructured":"Schrager LK, Vekemens J, Drager N, Lewinsohn DM, Olesen OF (2020) The status of tuberculosis vaccine development. Lancet Infect Dis 20(3):e28\u2013e37. https:\/\/doi.org\/10.1016\/S1473-3099(19)30625-5","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"4481_CR17","doi-asserted-by":"publisher","first-page":"5284","DOI":"10.1080\/21645515.2021.2007711","volume":"17","author":"M Qu","year":"2021","unstructured":"Qu M, Zhou X, Li H (2021) BCG vaccination strategies against tuberculosis: updates and perspectives. Hum Vaccin Immunother 17(12):5284\u20135295. https:\/\/doi.org\/10.1080\/21645515.2021.2007711","journal-title":"Hum Vaccin Immunother"},{"issue":"17","key":"4481_CR18","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1056\/NEJMoa1803484","volume":"379","author":"O Van Der Meeren","year":"2018","unstructured":"Van Der Meeren O, Hatherill M, Nduba V et al (2018) Phase 2b controlled trial of M72\/AS01E vaccine to prevent tuberculosis. N Engl J Med 379(17):1621\u20131634. https:\/\/doi.org\/10.1056\/NEJMoa1803484","journal-title":"N Engl J Med"},{"issue":"25","key":"4481_CR19","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1056\/NEJMoa1909953","volume":"381","author":"DR Tait","year":"2019","unstructured":"Tait DR, Hatherill M, Van Der Meeren O et al (2019) Final analysis of a trial of M72\/AS01E vaccine to prevent tuberculosis. N Engl J Med 381(25):2429\u20132439. https:\/\/doi.org\/10.1056\/NEJMoa1909953","journal-title":"N Engl J Med"},{"key":"4481_CR20","doi-asserted-by":"publisher","first-page":"597","DOI":"10.21775\/cimb.041.597","volume":"41","author":"MA Naeem","year":"2021","unstructured":"Naeem MA, Ahmad W, Tyagi R, Akram Q, Younus M, Liu X (2021) Stealth strategies of Mycobacterium tuberculosis for immune evasion. Curr Issues Mol Biol 41:597\u2013616. https:\/\/doi.org\/10.21775\/cimb.041.597","journal-title":"Curr Issues Mol Biol"},{"key":"4481_CR21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jinorgbio.2017.12.015","volume":"181","author":"JD Masson","year":"2018","unstructured":"Masson JD, Cr\u00e9peaux G, Authier FJ, Exley C, Gherardi RK (2018) Critical analysis of reference studies on the toxicokinetics of aluminum-based adjuvants. J Inorg Biochem 181:87\u201395. https:\/\/doi.org\/10.1016\/j.jinorgbio.2017.12.015","journal-title":"J Inorg Biochem"},{"issue":"14","key":"4481_CR22","doi-asserted-by":"publisher","first-page":"e3302","DOI":"10.21769\/BioProtoc.3302","volume":"9","author":"CJ Busch","year":"2019","unstructured":"Busch CJ, Favret J, Geirsd\u00f3ttir L, Molawi K, Sieweke MH (2019) Isolation and Long-term cultivation of mouse alveolar macrophages. Bio Protoc 9(14):e3302. https:\/\/doi.org\/10.21769\/BioProtoc.3302","journal-title":"Bio Protoc"},{"issue":"1","key":"4481_CR23","doi-asserted-by":"publisher","first-page":"22194","DOI":"10.1038\/s41598-023-49665-2","volume":"13","author":"S Yari","year":"2023","unstructured":"Yari S, Afrough P, Yari F, Ghazanfari Jajin M, Fateh A, Hadizadeh Tasbiti A (2023) A potent subset of Mycobacterium tuberculosis glycoproteins as relevant candidates for vaccine and therapeutic target. Sci Rep 13(1):22194. https:\/\/doi.org\/10.1038\/s41598-023-49665-2","journal-title":"Sci Rep"},{"key":"4481_CR24","doi-asserted-by":"publisher","first-page":"102307","DOI":"10.1016\/j.tube.2023.102307","volume":"139","author":"VT Duong","year":"2023","unstructured":"Duong VT, Skwarczynski M, Toth I (2023) Towards the development of subunit vaccines against tuberculosis: the key role of adjuvant. Tuberculosis (Edinb) 139:102307. https:\/\/doi.org\/10.1016\/j.tube.2023.102307","journal-title":"Tuberculosis (Edinb)"},{"key":"4481_CR25","doi-asserted-by":"publisher","first-page":"122632","DOI":"10.1016\/j.lfs.2024.122632","volume":"346","author":"H Verma","year":"2024","unstructured":"Verma H, Chauhan A, Kumar A, Kumar M, Kanchan K (2024) Synchronization of Mycobacterium life cycle: A possible novel mechanism of antimycobacterial drug resistance evolution and its manipulation. Life Sci 346:122632. https:\/\/doi.org\/10.1016\/j.lfs.2024.122632","journal-title":"Life Sci"},{"issue":"1","key":"4481_CR26","doi-asserted-by":"publisher","first-page":"2150449","DOI":"10.1080\/21505594.2022.2150449","volume":"14","author":"KC Rahlwes","year":"2023","unstructured":"Rahlwes KC, Dias BRS, Campos PC, Alvarez-Arguedas S, Shiloh MU (2023) Pathogenicity and virulence of Mycobacterium tuberculosis. Virulence 14(1):2150449. https:\/\/doi.org\/10.1080\/21505594.2022.2150449","journal-title":"Virulence"},{"issue":"5","key":"4481_CR27","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1093\/infdis\/jiae170","volume":"230","author":"D Tait","year":"2024","unstructured":"Tait D, Diacon A, Borges \u00c1H et al (2024) Safety and immunogenicity of the H56:IC31 tuberculosis vaccine candidate in adults successfully treated for Drug-Susceptible pulmonary tuberculosis: A phase 1 randomized trial. J Infect Dis 230(5):1262\u20131270. https:\/\/doi.org\/10.1093\/infdis\/jiae170","journal-title":"J Infect Dis"},{"issue":"6","key":"4481_CR28","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1007\/s40121-023-00806-0","volume":"12","author":"YH Choi","year":"2023","unstructured":"Choi YH, Kang YA, Park KJ et al (2023) Safety and immunogenicity of the ID93\u2009+\u2009GLA-SE tuberculosis vaccine in BCG-Vaccinated healthy adults: A Randomized, Double-Blind, Placebo-Controlled phase 2 trial. Infect Dis Ther 12(6):1605\u20131624. https:\/\/doi.org\/10.1007\/s40121-023-00806-0","journal-title":"Infect Dis Ther"},{"issue":"53","key":"4481_CR29","doi-asserted-by":"publisher","first-page":"53ra74","DOI":"10.1126\/scitranslmed.3001094","volume":"2","author":"S Bertholet","year":"2010","unstructured":"Bertholet S, Ireton GC, Ordway DJ et al (2010) A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis. Sci Transl Med 2(53):53ra74. https:\/\/doi.org\/10.1126\/scitranslmed.3001094","journal-title":"Sci Transl Med"},{"issue":"4","key":"4481_CR30","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S2213-2600(20)30319-2","volume":"9","author":"TA Day","year":"2021","unstructured":"Day TA, Penn-Nicholson A, Luabeya AKK et al (2021) Safety and immunogenicity of the adjunct therapeutic vaccine ID93\u2008+\u2008GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial. Lancet Respir Med 9(4):373\u2013386. https:\/\/doi.org\/10.1016\/S2213-2600(20)30319-2","journal-title":"Lancet Respir Med"},{"issue":"4","key":"4481_CR31","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3390\/vaccines9040396","volume":"9","author":"M Riste","year":"2021","unstructured":"Riste M, Marshall JL, Satti I et al (2021) Phase I trial evaluating the safety and immunogenicity of candidate TB vaccine MVA85A, delivered by aerosol to healthy M.tb-Infected adults. Vaccines (Basel) 9(4):396. https:\/\/doi.org\/10.3390\/vaccines9040396","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"4481_CR32","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3390\/vaccines8040652","volume":"8","author":"AP Tkachuk","year":"2020","unstructured":"Tkachuk AP, Bykonia EN, Popova LI et al (2020) Safety and immunogenicity of the GamTBvac, the Recombinant subunit tuberculosis vaccine candidate: A phase II, Multi-Center, Double-Blind, Randomized, Placebo-Controlled study. Vaccines (Basel) 8(4):652. https:\/\/doi.org\/10.3390\/vaccines8040652","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"4481_CR33","doi-asserted-by":"publisher","first-page":"49","DOI":"10.21037\/atm-21-6863","volume":"10","author":"C He","year":"2022","unstructured":"He C, Cheng X, Kaisaier A et al (2022) Effects of Mycobacterium tuberculosis lineages and regions of difference (RD) virulence gene variation on tuberculosis recurrence. Ann Transl Med 10(2):49. https:\/\/doi.org\/10.21037\/atm-21-6863","journal-title":"Ann Transl Med"},{"key":"4481_CR34","doi-asserted-by":"publisher","first-page":"1238586","DOI":"10.3389\/fimmu.2023.1238586","volume":"14","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Xu JC, Hu ZD et al (2023) Advances in protein subunit vaccines against tuberculosis. Front Immunol 14:1238586. https:\/\/doi.org\/10.3389\/fimmu.2023.1238586","journal-title":"Front Immunol"},{"issue":"9","key":"4481_CR35","doi-asserted-by":"publisher","first-page":"e1001100","DOI":"10.1371\/journal.ppat.1001100","volume":"6","author":"P Brodin","year":"2010","unstructured":"Brodin P, Poquet Y, Levillain F et al (2010) High content phenotypic cell-based visual screen identifies Mycobacterium tuberculosis acyltrehalose-containing glycolipids involved in phagosome remodeling. PLoS Pathog 6(9):e1001100. https:\/\/doi.org\/10.1371\/journal.ppat.1001100","journal-title":"PLoS Pathog"},{"issue":"9","key":"4481_CR36","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.3390\/microorganisms8091298","volume":"8","author":"HJ Lee","year":"2020","unstructured":"Lee HJ, Woo Y, Hahn TW, Jung YM, Jung YJ (2020) Formation and maturation of the phagosome: a key mechanism in innate immunity against intracellular bacterial infection. Microorganisms 8(9):1298. https:\/\/doi.org\/10.3390\/microorganisms8091298","journal-title":"Microorganisms"},{"issue":"1","key":"4481_CR37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0378-1097(04)00018-7","volume":"232","author":"JH Lim","year":"2004","unstructured":"Lim JH, Kim HJ, Lee KS et al (2004) Identification of the new T-cell-stimulating antigens from Mycobacterium tuberculosis culture filtrate. FEMS Microbiol Lett 232(1):51\u201359. https:\/\/doi.org\/10.1016\/S0378-1097(04)00018-7","journal-title":"FEMS Microbiol Lett"},{"key":"4481_CR38","doi-asserted-by":"publisher","first-page":"106195","DOI":"10.1016\/j.phrs.2022.106195","volume":"179","author":"J Sui","year":"2022","unstructured":"Sui J, Qiao W, Xiang X, Luo Y (2022) Epigenetic changes in Mycobacterium tuberculosis and its host provide potential targets or biomarkers for drug discovery and clinical diagnosis. Pharmacol Res 179:106195. https:\/\/doi.org\/10.1016\/j.phrs.2022.106195","journal-title":"Pharmacol Res"},{"key":"4481_CR39","doi-asserted-by":"publisher","first-page":"102635","DOI":"10.1016\/j.tube.2025.102635","volume":"152","author":"X Wang","year":"2025","unstructured":"Wang X, Xu Y, Zhong Q et al (2025) Construction and expression of multi-stage antigen fusion protein RPC4 vaccine for Mycobacterium tuberculosis and its immunogenicity analysis in combination with adjuvant DIMQ. Tuberculosis (Edinb) 152:102635. https:\/\/doi.org\/10.1016\/j.tube.2025.102635","journal-title":"Tuberculosis (Edinb)"},{"key":"4481_CR40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/112_2018_9","volume":"175","author":"F Khademi","year":"2018","unstructured":"Khademi F, Taheri RA, Momtazi-Borojeni AA, Farnoosh G, Johnston TP, Sahebkar A (2018) Potential of cationic liposomes as Adjuvants\/Delivery systems for tuberculosis subunit vaccines. Rev Physiol Biochem Pharmacol 175:47\u201369. https:\/\/doi.org\/10.1007\/112_2018_9","journal-title":"Rev Physiol Biochem Pharmacol"},{"issue":"2","key":"4481_CR41","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jconrel.2009.10.022","volume":"142","author":"M Henriksen-Lacey","year":"2010","unstructured":"Henriksen-Lacey M, Bramwell VW, Christensen D et al (2010) Liposomes based on dimethyldioctadecylammonium promote a depot effect and enhance immunogenicity of soluble antigen. J Control Release 142(2):180\u2013186. https:\/\/doi.org\/10.1016\/j.jconrel.2009.10.022","journal-title":"J Control Release"},{"issue":"2","key":"4481_CR42","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/j.1365-2567.2007.02560.x","volume":"121","author":"KS Korsholm","year":"2007","unstructured":"Korsholm KS, Agger EM, Foged C et al (2007) The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes. Immunology 121(2):216\u2013226. https:\/\/doi.org\/10.1111\/j.1365-2567.2007.02560.x","journal-title":"Immunology"},{"issue":"5","key":"4481_CR43","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1038\/s41423-021-00669-w","volume":"18","author":"R Zhang","year":"2021","unstructured":"Zhang R, Wang C, Guan Y et al (2021) Manganese salts function as potent adjuvants. Cell Mol Immunol 18(5):1222\u20131234. https:\/\/doi.org\/10.1038\/s41423-021-00669-w","journal-title":"Cell Mol Immunol"},{"issue":"23","key":"4481_CR44","doi-asserted-by":"publisher","first-page":"e0141421","DOI":"10.1128\/JVI.01414-21","volume":"95","author":"Z Wang","year":"2021","unstructured":"Wang Z, Yuan Y, Chen C et al (2021) Colloidal manganese salt improves the efficacy of rabies vaccines in Mice, Cats, and dogs. J Virol 95(23):e0141421. https:\/\/doi.org\/10.1128\/JVI.01414-21","journal-title":"J Virol"},{"issue":"4","key":"4481_CR45","doi-asserted-by":"publisher","first-page":"e0347723","DOI":"10.1128\/spectrum.03477-23","volume":"12","author":"J Wang","year":"2024","unstructured":"Wang J, Liu L, Zong X et al (2024) Immunogenicity and protective efficacy of a novel bacterium-like particle-based vaccine displaying canine distemper virus antigens in mice and dogs. Microbiol Spectr 12(4):e0347723. https:\/\/doi.org\/10.1128\/spectrum.03477-23","journal-title":"Microbiol Spectr"},{"key":"4481_CR46","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.3389\/fmicb.2020.01684","volume":"11","author":"HJ Lee","year":"2020","unstructured":"Lee HJ, Kang SJ, Woo Y et al (2020) TLR7 stimulation with imiquimod induces selective autophagy and controls Mycobacterium tuberculosis growth in mouse macrophages. Front Microbiol 11:1684. https:\/\/doi.org\/10.3389\/fmicb.2020.01684","journal-title":"Front Microbiol"},{"key":"4481_CR47","doi-asserted-by":"publisher","unstructured":"Lyadova IV, Panteleev AV (2015) Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and Biomarkers. Mediators Inflamm 2015:854507. https:\/\/doi.org\/10.1155\/2015\/854507","DOI":"10.1155\/2015\/854507"},{"issue":"4804","key":"4481_CR48","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1126\/science.3107127","volume":"236","author":"CM Snapper","year":"1987","unstructured":"Snapper CM, Paul WE (1987) Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236(4804):944\u2013947. https:\/\/doi.org\/10.1126\/science.3107127","journal-title":"Science"},{"issue":"3","key":"4481_CR49","doi-asserted-by":"publisher","first-page":"e1007643","DOI":"10.1371\/journal.ppat.1007643","volume":"15","author":"MJ Rodo","year":"2019","unstructured":"Rodo MJ, Rozot V, Nemes E et al (2019) A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates. PLoS Pathog 15(3):e1007643. https:\/\/doi.org\/10.1371\/journal.ppat.1007643","journal-title":"PLoS Pathog"},{"key":"4481_CR50","doi-asserted-by":"publisher","first-page":"1430955","DOI":"10.3389\/fimmu.2024.1430955","volume":"15","author":"Q Wang","year":"2024","unstructured":"Wang Q, Nag D, Baldwin SL, Coler RN, McNamara RP (2024) Antibodies as key mediators of protection against Mycobacterium tuberculosis. Front Immunol 15:1430955. https:\/\/doi.org\/10.3389\/fimmu.2024.1430955","journal-title":"Front Immunol"},{"key":"4481_CR51","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.coi.2018.04.004","volume":"53","author":"JM Achkar","year":"2018","unstructured":"Achkar JM, Prados-Rosales R (2018) Updates on antibody functions in Mycobacterium tuberculosis infection and their relevance for developing a vaccine against tuberculosis. Curr Opin Immunol 53:30\u201337. https:\/\/doi.org\/10.1016\/j.coi.2018.04.004","journal-title":"Curr Opin Immunol"},{"issue":"6","key":"4481_CR52","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/0035-9203(92)90192-f","volume":"86","author":"AM Costello","year":"1992","unstructured":"Costello AM, Kumar A, Narayan V et al (1992) Does antibody to mycobacterial antigens, including lipoarabinomannan, limit dissemination in childhood tuberculosis? Trans R Soc Trop Med Hyg 86(6):686\u2013692. https:\/\/doi.org\/10.1016\/0035-9203(92)90192-f","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4","key":"4481_CR53","doi-asserted-by":"publisher","first-page":"e0294224","DOI":"10.1128\/spectrum.02942-24","volume":"13","author":"H Li","year":"2025","unstructured":"Li H, Ji J, Qu M et al (2025) Isolation and characterization of a protective monoclonal antibody targeting outer membrane protein (OmpA) against tuberculosis. Microbiol Spectr 13(4):e0294224. https:\/\/doi.org\/10.1128\/spectrum.02942-24","journal-title":"Microbiol Spectr"},{"issue":"1","key":"4481_CR54","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1365-2249.2004.02593.x","volume":"138","author":"B Hamasur","year":"2004","unstructured":"Hamasur B, Haile M, Pawlowski A et al (2004) A mycobacterial Lipoarabinomannan specific monoclonal antibody and its F(ab\u2019) fragment prolong survival of mice infected with Mycobacterium tuberculosis. Clin Exp Immunol 138(1):30\u201338. https:\/\/doi.org\/10.1111\/j.1365-2249.2004.02593.x","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"4481_CR55","doi-asserted-by":"publisher","first-page":"6101","DOI":"10.1128\/IAI.73.9.6101-6109.2005","volume":"73","author":"E Roy","year":"2005","unstructured":"Roy E, Stavropoulos E, Brennan J et al (2005) Therapeutic efficacy of high-dose intravenous Immunoglobulin in Mycobacterium tuberculosis infection in mice. Infect Immun 73(9):6101\u20136109. https:\/\/doi.org\/10.1128\/IAI.73.9.6101-6109.2005","journal-title":"Infect Immun"},{"issue":"1","key":"4481_CR56","doi-asserted-by":"publisher","first-page":"15560","DOI":"10.1038\/s41598-019-52146-0","volume":"9","author":"KW Kwon","year":"2019","unstructured":"Kwon KW, Lee A, Larsen SE et al (2019) Long-term protective efficacy with a BCG-prime ID93\/GLA-SE boost regimen against the hyper-virulent Mycobacterium tuberculosis strain K in a mouse model. Sci Rep 9(1):15560. https:\/\/doi.org\/10.1038\/s41598-019-52146-0","journal-title":"Sci Rep"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-025-04481-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-025-04481-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-025-04481-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T08:27:50Z","timestamp":1761380870000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-025-04481-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":56,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["4481"],"URL":"https:\/\/doi.org\/10.1007\/s00203-025-04481-2","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"type":"print","value":"0302-8933"},{"type":"electronic","value":"1432-072X"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"1 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Volunteers participating in this experiment have given informed consent to participate in this study, which has been approved by the Affiliated Cancer Hospital Committee of Anhui University of Science and Technology. Animal experiments have been approved by the Animal Experiment Committee of Anhui University of Science and Technology (No. GZ2022-003). Animal care is in accordance with institutional guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"290"}}